| 000 | 01431 a2200337 4500 | ||
|---|---|---|---|
| 005 | 20250518084548.0 | ||
| 264 | 0 | _c20201222 | |
| 008 | 202012s 0 0 eng d | ||
| 022 | _a1477-092X | ||
| 024 | 7 |
_a10.1177/1078155220904406 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aBrener, Zachary Z | |
| 245 | 0 | 0 |
_aBruton's tyrosine kinase inhibitors and the kidney: Focus on ibrutinib. _h[electronic resource] |
| 260 |
_bJournal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners _cOct 2020 |
||
| 300 |
_a1735-1737 p. _bdigital |
||
| 500 | _aPublication Type: Case Reports; Journal Article | ||
| 650 | 0 | 4 |
_aAdenine _xadministration & dosage |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aKidney _xdrug effects |
| 650 | 0 | 4 |
_aLeukemia, Lymphocytic, Chronic, B-Cell _xdrug therapy |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 |
_aPiperidines _xadministration & dosage |
| 650 | 0 | 4 |
_aProtein Kinase Inhibitors _xadverse effects |
| 650 | 0 | 4 |
_aTumor Lysis Syndrome _xetiology |
| 650 | 0 | 4 |
_aUrate Oxidase _xadministration & dosage |
| 700 | 1 | _aBrener, Heather | |
| 700 | 1 | _aLosev, Alexander | |
| 773 | 0 |
_tJournal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners _gvol. 26 _gno. 7 _gp. 1735-1737 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1177/1078155220904406 _zAvailable from publisher's website |
| 999 |
_c30630919 _d30630919 |
||